Iron Restriction Alleviates Atherosclerosis in ApoE KO Mice: An iTRAQ Proteomic Analysis

被引:4
|
作者
Luo, Gang [1 ]
Xiang, Lu [1 ]
Xiao, Lin [1 ]
机构
[1] Cent South Univ, Xiangya Sch Publ Hlth, Changsha 410078, Peoples R China
基金
中国国家自然科学基金;
关键词
atherosclerosis; iron; iTRAQ; Gal-3; VCAM1; LESION DEVELOPMENT; MYOCARDIAL-INFARCTION; BODY IRON; OVERLOAD; LIVER; RISK; SEX; DIET; DESFERRIOXAMINE; CHELATOR;
D O I
10.3390/ijms232415915
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The "iron hypothesis" of atherosclerosis has long been controversial. Several studies have shown that dietary iron restriction or low-iron diets can effectively alleviate atherosclerosis in rabbits and mice. However, the underlying molecular mechanisms of these phenomena remain to be elucidated. In this study, we further evaluated possible correlations between a low-iron diet and atherosclerosis alleviation by using a quantitative proteomic approach. For this purpose, apolipoprotein E knockout (ApoE KO) mice were divided into three groups and fed a normal diet (ND), a high-fat diet (HFD), or a high-fat +low-iron diet (HFD + LI). Our results showed that the HFD-LI improved atherosclerosis by decreasing en face lesions of the aorta and reducing the accumulation of macrophages and disordered smooth muscle cells. HFD-LI also decreased iron levels, serum hepcidin levels and the serum concentration of low-density lipoprotein cholesterol (LDL-C). The use of the isobaric tag for absolute quantification (iTRAQ) proteomic method and subsequent multi-technique molecular validation indicated that many of the proteins involved in atherosclerotic inflammation, vascular remodeling, and focal adhesion had significant changes in their expression among the diet groups. Importantly, the proteins Gal-3 and VCAM1, which are key participants of atherosclerosis pathogenesis, revealed lower expression after a low-iron diet. The present findings widely support the "iron hypothesis" of atherosclerosis. Further studies are suggested to fully understand the implications of these results.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Rosiglitazone reduces atherosclerosis in ApoE KO mice
    Benson, GM
    Grimsditch, DC
    Vidgeon-Hart, M
    Overend, P
    Smith, SA
    DIABETES, 2001, 50 : A80 - A80
  • [2] Mononuclear cell therapy attenuates atherosclerosis in apoE KO mice
    Marcella L Porto
    Leandro CF Lima
    Thiago MC Pereira
    Breno V Nogueira
    Clarissa L Tonini
    Bianca P Campagnaro
    Silvana S Meyrelles
    Elisardo C Vasquez
    Lipids in Health and Disease, 10
  • [3] Mononuclear cell therapy attenuates atherosclerosis in apoE KO mice
    Porto, Marcella L.
    Lima, Leandro C. F.
    Pereira, Thiago M. C.
    Nogueira, Breno V.
    Tonini, Clarissa L.
    Campagnaro, Bianca P.
    Meyrelles, Silvana S.
    Vasquez, Elisardo C.
    LIPIDS IN HEALTH AND DISEASE, 2011, 10
  • [4] Role of natural killer cells in atherosclerosis in ApoE KO mice
    Xiao, JY
    Shah, K
    Koprak, S
    Ding, G
    Fischer, P
    McNamara, L
    Rickes, E
    Chang, R
    Wu, TJ
    Cheng, K
    Springer, M
    Koo, GC
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (05) : E95 - E95
  • [5] Hepatic lipase expression in macrophages modulates aortic atherosclerosis in apoE-KO mice: Bone marrow transplantation in apoE-KO and apoE-KO x HL-KO mice
    Nong, ZX
    Amar, MJ
    Gonzalez, H
    Vaisman, BL
    Paigen, B
    Bensadoun, A
    Neufeld, EB
    Brewer, HB
    Santamarina-Fojo, S
    CIRCULATION, 2001, 104 (17) : 268 - 269
  • [6] RUPATADINE DOES NOT AFFECT ATHEROSCLEROSIS DEVELOPMENT IN APOE-KO MICE
    Chiesa, G.
    Busnelli, M.
    Capparini, L.
    Manzini, S.
    ATHEROSCLEROSIS, 2019, 287 : E250 - E251
  • [7] Evolution of angiotensin II-mediated atherosclerosis in ApoE KO mice
    Cha, John
    Ivanov, Vadim
    Ivanova, Svetlana
    Kalinovsky, Tatiana
    Rath, Matthias
    Niedzwiecki, Aleksandra
    MOLECULAR MEDICINE REPORTS, 2010, 3 (04) : 565 - 570
  • [8] Protective effects of imeglimin on the development of atherosclerosis in ApoE KO mice treated with STZ
    Sanada, Junpei
    Kimura, Tomohiko
    Shimoda, Masashi
    Iwamoto, Yuichiro
    Iwamoto, Hideyuki
    Dan, Kazunori
    Fushimi, Yoshiro
    Katakura, Yukino
    Nogami, Yuka
    Shirakiya, Yoshiko
    Yamasaki, Yuki
    Ikeda, Tomoko
    Nakanishi, Shuhei
    Mune, Tomoatsu
    Kaku, Kohei
    Kaneto, Hideaki
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
  • [9] Protective effects of imeglimin on the development of atherosclerosis in ApoE KO mice treated with STZ
    Junpei Sanada
    Tomohiko Kimura
    Masashi Shimoda
    Yuichiro Iwamoto
    Hideyuki Iwamoto
    Kazunori Dan
    Yoshiro Fushimi
    Yukino Katakura
    Yuka Nogami
    Yoshiko Shirakiya
    Yuki Yamasaki
    Tomoko Ikeda
    Shuhei Nakanishi
    Tomoatsu Mune
    Kohei Kaku
    Hideaki Kaneto
    Cardiovascular Diabetology, 23
  • [10] Time-Restricted Feeding Reduces Atherosclerosis in LDLR KO Mice but Not in ApoE Knockout Mice
    Chaix, Amandine
    Lin, Terry
    Ramms, Bastian
    Cutler, Roy G.
    Le, Tiffani
    Lopez, Catherine
    Miu, Phuong
    Pinto, Antonio F. M.
    Saghatelian, Alan
    Playford, Martin P.
    Mehta, Nehal N.
    Mattson, Mark P.
    Gordts, Philip
    Witztum, Joseph L.
    Panda, Satchidananda
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2024, 44 (09) : 2069 - 2087